---
schema_version: "secwatch.filing_event.v1"
accession: "0001638833-23-000002"
form_type: "8-K"
ticker: "SGRY"
cik: "0001638833"
company_name: "Surgery Partners, Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:53:54.250591+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Surgery Partners reaffirms 2022 revenue and Adj. EBITDA guidance at J.P. Morgan conference

## Summary
- Reaffirms 2022 revenue guidance of $2.50B to $2.55B.
- Reaffirms 2022 Adjusted EBITDA guidance of $375M to $385M.
- Guidance based on results through November 2022; year-end adjustments pending.
- Management presenting at 41st Annual J.P. Morgan Healthcare Conference on Jan 9, 2023.

## SEC filing metadata
- accession: 0001638833-23-000002
- form_type: 8-K
- ticker: SGRY
- cik: 0001638833
- company_name: Surgery Partners, Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000002/0001638833-23-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000002/sgry-20230109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001638833-23-000002
- JSON: https://secwatch.observer/filing/0001638833-23-000002.json
- Plain text: https://secwatch.observer/filing/0001638833-23-000002.txt

## Key facts
- Earnings Releases
  Surgery Partners, Inc. reported the fiscal year ended December 31, 2022 results: revenue $2.50 billion to $2.55 billion. Guidance reaffirmed.
  - Period: the fiscal year ended December 31, 2022
  - Revenue: $2.50 billion to $2.55 billion
  - Guidance: reaffirmed
  - Result: guidance update
  source text: Based on results through November 2022, the Company is re-affirming its 2022 Adjusted EBITDA guidance of $375 million to $385 million and its 2022 Revenue guidance of $2.50 billion to $2.55 billion.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000002/0001638833-23-000002-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.